Skip directly to content

Minimize RSR Award Detail

Research Spending & Results

Award Detail

Awardee:BALLYDEL TECHNOLOGIES INC.
Doing Business As Name:BALLYDEL TECHNOLOGIES INC.
PD/PI:
  • Brendan G DeLacy
  • (610) 304-0606
  • info@ballydel.com
Award Date:05/13/2021
Estimated Total Award Amount: $ 256,000
Funds Obligated to Date: $ 256,000
  • FY 2021=$256,000
Start Date:05/15/2021
End Date:04/30/2022
Transaction Type:Grant
Agency:NSF
Awarding Agency Code:4900
Funding Agency Code:4900
CFDA Number:47.041
Primary Program Source:040100 NSF RESEARCH & RELATED ACTIVIT
Award Title or Description:SBIR Phase I: Tagging and Authentication Technology for Vaccines (COVID-19)
Federal Award ID Number:2111844
DUNS ID:117128340
Program:SBIR Phase I
Program Officer:
  • Kaitlin Bratlie
  • (703) 292-2638
  • kbratlie@nsf.gov

Awardee Location

Street:204 SECRETARIAT DR UNIT B
City:HAVRE DE GRACE
State:MD
ZIP:21078-2653
County:Havre de Grace
Country:US
Awardee Cong. District:02

Primary Place of Performance

Organization Name:Ballydel Technologies Inc.
Street:550 South College Ave., Ste. 110
City:Newark
State:DE
ZIP:19713-1324
County:Newark
Country:US
Cong. District:00

Abstract at Time of Award

The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a state-of-the-art, counterfeit-proof security technology to enable vaccine manufacturers to tag, track, and authenticate vaccine products throughout the supply chain. The tagging process will be amenable to its integration into a scalable glass vial manufacturing process. Digital information such as product, lot number, expiry, etc. may be embedded into the tags, if desired. In light of the current global COVID-19 pandemic, security and authentication of vaccine dosages throughout the supply chain represents a significant public health and global logistics challenge. Industry concerns over vaccine theft and counterfeit products drive the market need for an effective ID security technology that enable manufacturers to authenticate vaccines in a safe, covert, and efficient manner. The tagging process developed in this program will add minimal expenses to the manufacturing cost of each vaccine dosage form, at an estimated cost of pennies per dose. This Small Business Innovation Research (SBIR) Phase I project will require the completion of several tasks, including: 1) the computational design of the taggant patterns, 2) the development of a scalable tagging process, 3) the development of instrumentation and associated software for tag authentication, and 4) the encryption of tags with digital information such as lot number, expiry, manufacturing location, or any other desired product information. In summary, the specific design parameters of the tag will be elucidated and optimized during this Phase I effort. The design parameters will subsequently be demonstrated on flat glass and glass vaccine vial prototypes using a scalable process. Finally, newly developed “reading” instrumentation will be used to authenticate the tagged glass prototypes, demonstrating the overall utility of this anti-counterfeit technology. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

For specific questions or comments about this information including the NSF Project Outcomes Report, contact us.